{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T01:11:35Z","timestamp":1786237895970,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Construction Project of the Key Project of Medical Science and Technology of Henan Province of China","award":["YNQN2017053"],"award-info":[{"award-number":["YNQN2017053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s13402-024-01013-w","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T14:40:42Z","timestamp":1732545642000},"page":"487-504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Lenvatinib-activated NDUFA4L2\/IL33\/PADI4 pathway induces neutrophil extracellular traps that inhibit cuproptosis in hepatocellular carcinoma"],"prefix":"10.1007","volume":"48","author":[{"given":"Nan","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"1013_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","volume":"391","author":"M Kudo","year":"2018","unstructured":"M. Kudo, R.S. Finn, S. Qin, K.H. Han, K. Ikeda, F. Piscaglia, A. Baron, J.W. Park, G. Han, J. Jassem, J.F. Blanc, A. Vogel, D. Komov, T.R.J. Evans, C. Lopez, C. Dutcus, M. Guo, K. Saito, S. Kraljevic, T. Tamai, M. Ren, A.L. Cheng, Lenvatinib versus Sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 391, 1163\u20131173 (2018). https:\/\/doi.org\/10.1016\/S0140-6736(18)30207-1","journal-title":"Lancet"},{"key":"1013_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000531820","volume":"13","author":"M Ikeda","year":"2024","unstructured":"M. Ikeda, T. Yamashita, S. Ogasawara, M. Kudo, Y. Inaba, M. Morimoto, K. Tsuchiya, S. Shimizu, Y. Kojima, A. Hiraoka, K. Nouso, H. Aikata, K. Numata, T. Sato, T. Okusaka, J. Furuse, Multicenter Phase II Trial of Lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD. Liver Cancer. 13, 193\u2013202 (2024). https:\/\/doi.org\/10.1159\/000531820","journal-title":"Liver Cancer"},{"key":"1013_CR3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3350\/cmh.2023.0114","volume":"29","author":"LL Chan","year":"2023","unstructured":"L.L. Chan, S.L. Chan, The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment. Clin. Mol. Hepatol. 29, 909\u2013923 (2023). https:\/\/doi.org\/10.3350\/cmh.2023.0114","journal-title":"Clin. Mol. Hepatol."},{"key":"1013_CR4","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","volume":"595","author":"H Jin","year":"2021","unstructured":"H. Jin, Y. Shi, Y. Lv, S. Yuan, C.F.A. Ramirez, C. Lieftink, L. Wang, S. Wang, C. Wang, M.H. Dias, F. Jochems, Y. Yang, A. Bosma, E.M. Hijmans, M.H.P. de Groot, S. Vegna, D. Cui, Y. Zhou, J. Ling, H. Wang, Y. Guo, X. Zheng, N. Isima, H. Wu, C. Sun, R.L. Beijersbergen, L. Akkari, W. Zhou, B. Zhai, W. Qin, R. Bernards, EGFR activation limits the response of liver cancer to lenvatinib. Nature. 595, 730\u2013734 (2021). https:\/\/doi.org\/10.1038\/s41586-021-03741-7","journal-title":"Nature"},{"key":"1013_CR5","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/s41467-024-45247-6","volume":"15","author":"S Spahn","year":"2024","unstructured":"S. Spahn, F. Kleinhenz, E. Shevchenko, A. Stahl, Y. Rasen, C. Geisler, K. Ruhm, M. Klaumuenzer, T. Kronenberger, S.A. Laufer, H. Sundberg-Malek, K.C. Bui, M. Horger, S. Biskup, K. Schulze-Osthoff, M. Templin, N.P. Malek, A. Poso, M. Bitzer, The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma. Nat. Commun. 15, 1287 (2024). https:\/\/doi.org\/10.1038\/s41467-024-45247-6","journal-title":"Nat. Commun."},{"key":"1013_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jare.2022.03.012","volume":"44","author":"W Tan","year":"2023","unstructured":"W. Tan, K. Zhang, X. Chen, L. Yang, S. Zhu, Y. Wei, Z. Xie, Y. Chen, C. Shang, GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma. J. Adv. Res. 44, 173\u2013183 (2023). https:\/\/doi.org\/10.1016\/j.jare.2022.03.012","journal-title":"J. Adv. Res."},{"key":"1013_CR7","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/cas.15378","volume":"113","author":"N Iseda","year":"2022","unstructured":"N. Iseda, S. Itoh, K. Toshida, T. Tomiyama, A. Morinaga, M. Shimokawa, T. Shimagaki, H. Wang, T. Kurihara, T. Toshima, Y. Nagao, N. Harada, T. Yoshizumi, M. Mori, Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma. Cancer Sci. 113, 2272\u20132287 (2022). https:\/\/doi.org\/10.1111\/cas.15378","journal-title":"Cancer Sci."},{"key":"1013_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15953","author":"Y Qin","year":"2024","unstructured":"Y. Qin, S. Han, Y. Yu, D. Qi, M. Ran, M. Yang, Y. Liu, Y. Li, L. Lu, Y. Liu, Y. Li, Lenvatinib in hepatocellular carcinoma: resistance mechanisms and strategies for improved efficacy. Liver Int. (2024). https:\/\/doi.org\/10.1111\/liv.15953","journal-title":"Liver Int."},{"key":"1013_CR9","doi-asserted-by":"publisher","first-page":"1153991","DOI":"10.3389\/fphar.2023.1153991","volume":"14","author":"W Bo","year":"2023","unstructured":"W. Bo, Y. Chen, Lenvatinib resistance mechanism and potential ways to conquer. Front. Pharmacol. 14, 1153991 (2023). https:\/\/doi.org\/10.3389\/fphar.2023.1153991","journal-title":"Front. Pharmacol."},{"key":"1013_CR10","doi-asserted-by":"publisher","first-page":"100976","DOI":"10.1016\/j.drup.2023.100976","volume":"69","author":"S Wang","year":"2023","unstructured":"S. Wang, L. Zhou, N. Ji, C. Sun, L. Sun, J. Sun, Y. Du, N. Zhang, Y. Li, W. Liu, W. Lu, Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression. Drug Resist. Updat. 69, 100976 (2023). https:\/\/doi.org\/10.1016\/j.drup.2023.100976","journal-title":"Drug Resist. Updat"},{"key":"1013_CR11","doi-asserted-by":"publisher","first-page":"216122","DOI":"10.1016\/j.canlet.2023.216122","volume":"559","author":"L Wang","year":"2023","unstructured":"L. Wang, Q. Yang, Q. Zhou, F. Fang, K. Lei, Z. Liu, G. Zheng, L. Zhu, J. Huo, X. Li, S. Peng, M. Kuang, S. Lin, M. Huang, L. Xu, METTL3-m(6)A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma. Cancer Lett. 559, 216122 (2023). https:\/\/doi.org\/10.1016\/j.canlet.2023.216122","journal-title":"Cancer Lett."},{"key":"1013_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1158\/0008-5472.CAN-22-0963","volume":"83","author":"M Huang","year":"2023","unstructured":"M. Huang, J. Long, Z. Yao, Y. Zhao, Y. Zhao, J. Liao, K. Lei, H. Xiao, Z. Dai, S. Peng, S. Lin, L. Xu, M. Kuang, METTL1-Mediated m7G tRNA modification promotes Lenvatinib Resistance in Hepatocellular Carcinoma. Cancer Res. 83, 89\u2013102 (2023). https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-0963","journal-title":"Cancer Res."},{"key":"1013_CR13","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1080\/15548627.2022.2117893","volume":"19","author":"J Pan","year":"2023","unstructured":"J. Pan, M. Zhang, L. Dong, S. Ji, J. Zhang, S. Zhang, Y. Lin, X. Wang, Z. Ding, S. Qiu, D. Gao, J. Zhou, J. Fan, Q. Gao, Genome-scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma. Autophagy. 19, 1184\u20131198 (2023). https:\/\/doi.org\/10.1080\/15548627.2022.2117893","journal-title":"Autophagy"},{"key":"1013_CR14","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1158\/0008-5472.CAN-21-4140","volume":"82","author":"B Hu","year":"2022","unstructured":"B. Hu, T. Zou, W. Qin, X. Shen, Y. Su, J. Li, Y. Chen, Z. Zhang, H. Sun, Y. Zheng, C.Q. Wang, Z. Wang, T.E. Li, S. Wang, L. Zhu, X. Wang, Y. Fu, X. Ren, Q. Dong, L.X. Qin, Inhibition of EGFR overcomes acquired Lenvatinib Resistance Driven by STAT3-ABCB1 signaling in Hepatocellular Carcinoma. Cancer Res. 82, 3845\u20133857 (2022). https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-4140","journal-title":"Cancer Res."},{"key":"1013_CR15","doi-asserted-by":"publisher","first-page":"6699","DOI":"10.1038\/s41467-023-42360-w","volume":"14","author":"CON Leung","year":"2023","unstructured":"C.O.N. Leung, Y. Yang, R.W.H. Leung, K.K.H. So, H.J. Guo, M.M.L. Lei, G.K. Muliawan, Y. Gao, Q.Q. Yu, J.P. Yun, S. Ma, Q. Zhao, T.K.W. Lee, Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma. Nat. Commun. 14, 6699 (2023). https:\/\/doi.org\/10.1038\/s41467-023-42360-w","journal-title":"Nat. Commun."},{"key":"1013_CR16","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.gastro.2023.01.041","volume":"164","author":"J Wang","year":"2023","unstructured":"J. Wang, H. Yu, W. Dong, C. Zhang, M. Hu, W. Ma, X. Jiang, H. Li, P. Yang, D. Xiang, N6-Methyladenosine-mediated Up-Regulation of FZD10 regulates Liver Cancer Stem cells\u2019 properties and Lenvatinib Resistance through WNT\/beta-Catenin and Hippo Signaling Pathways. Gastroenterology. 164, 990\u20131005 (2023). https:\/\/doi.org\/10.1053\/j.gastro.2023.01.041","journal-title":"Gastroenterology"},{"key":"1013_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/cac2.12414","volume":"43","author":"JW Eun","year":"2023","unstructured":"J.W. Eun, J.H. Yoon, H.R. Ahn, S. Kim, Y.B. Kim, S.B. Lim, W. Park, T.W. Kang, G.O. Baek, M.G. Yoon, J.A. Son, J.H. Weon, S.S. Kim, H.J. Cho, J.Y. Cheong, Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib. Cancer Commun. (Lond). 43, 455\u2013479 (2023). https:\/\/doi.org\/10.1002\/cac2.12414","journal-title":"Cancer Commun. (Lond)"},{"key":"1013_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41575-021-00568-5","volume":"19","author":"D Geh","year":"2022","unstructured":"D. Geh, J. Leslie, R. Rumney, H.L. Reeves, T.G. Bird, D.A. Mann, Neutrophils as potential therapeutic targets in hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 19, 257\u2013273 (2022). https:\/\/doi.org\/10.1038\/s41575-021-00568-5","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1013_CR19","doi-asserted-by":"publisher","unstructured":"H. Deng, A. Kan, N. Lyu, M. He, X. Huang, S. Qiao, S. Li, W. Lu, Q. Xie, H. Chen, J. Lai, Q. Chen, X. Jiang, S. Liu, Z. Zhang, M. Zhao, Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma. J. Immunother. Cancer. 9 (2021). https:\/\/doi.org\/10.1136\/jitc-2020-002305","DOI":"10.1136\/jitc-2020-002305"},{"key":"1013_CR20","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1111\/cas.13806","volume":"109","author":"T Kimura","year":"2018","unstructured":"T. Kimura, Y. Kato, Y. Ozawa, K. Kodama, J. Ito, K. Ichikawa, K. Yamada, Y. Hori, K. Tabata, K. Takase, J. Matsui, Y. Funahashi, K. Nomoto, Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1-6 hepatocellular carcinoma model. Cancer Sci. 109, 3993\u20134002 (2018). https:\/\/doi.org\/10.1111\/cas.13806","journal-title":"Cancer Sci."},{"key":"1013_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.21873\/invivo.11828","volume":"34","author":"N Fukuda","year":"2020","unstructured":"N. Fukuda, X. Wang, A. Ohmoto, T. Urasaki, Y. Sato, K. Nakano, M. Nishizawa, M. Yunokawa, M. Ono, J. Tomomatsu, S. Takahashi, Sequential analysis of Neutrophil-to-lymphocyte ratio for differentiated thyroid Cancer patients treated with Lenvatinib. Vivo. 34, 709\u2013714 (2020). https:\/\/doi.org\/10.21873\/invivo.11828","journal-title":"Vivo"},{"key":"1013_CR22","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/liv.14405","volume":"40","author":"T Tada","year":"2020","unstructured":"T. Tada, T. Kumada, A. Hiraoka, K. Michitaka, M. Atsukawa, M. Hirooka, K. Tsuji, T. Ishikawa, K. Takaguchi, K. Kariyama, E. Itobayashi, K. Tajiri, N. Shimada, H. Shibata, H. Ochi, S. Yasuda, H. Toyoda, S. Fukunishi, H. Ohama, K. Kawata, S. Nakamura, K. Nouso, A. Tsutsui, T. Nagano, N. Itokawa, K. Hayama, T. Arai, M. Imai, K. Joko, Y. Koizumi, Y. Hiasa, Neutrophil-to-lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib. Liver Int. 40, 968\u2013976 (2020). https:\/\/doi.org\/10.1111\/liv.14405","journal-title":"Liver Int."},{"key":"1013_CR23","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.2147\/JHC.S432134","volume":"10","author":"Y Xiao","year":"2023","unstructured":"Y. Xiao, G. Zhu, J. Xie, L. Luo, W. Deng, L. Lin, J. Tao, Z. Hu, R. Shan, Pretreatment neutrophil-to-lymphocyte ratio as prognostic biomarkers in patients with unresectable hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy combined with lenvatinib and camrelizumab. J. Hepatocell Carcinoma. 10, 2049\u20132058 (2023). https:\/\/doi.org\/10.2147\/JHC.S432134","journal-title":"J. Hepatocell Carcinoma"},{"key":"1013_CR24","doi-asserted-by":"publisher","unstructured":"L.Y. Yang, Q. Luo, L. Lu, W.W. Zhu, H.T. Sun, R. Wei, Z.F. Lin, X.Y. Wang, C.Q. Wang, M. Lu, H.L. Jia, J.H. Chen, J.B. Zhang, L.X. Qin, Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response. J. Hematol. Oncol. 13, 3 (2020). https:\/\/doi.org\/10.1186\/s13045-019-0836-0","DOI":"10.1186\/s13045-019-0836-0"},{"key":"1013_CR25","doi-asserted-by":"publisher","first-page":"2052418","DOI":"10.1080\/2162402X.2022.2052418","volume":"11","author":"ZZ Jiang","year":"2022","unstructured":"Z.Z. Jiang, Z.P. Peng, X.C. Liu, H.F. Guo, M.M. Zhou, D. Jiang, W.R. Ning, Y.F. Huang, L. Zheng, Y. Wu, Neutrophil extracellular traps induce tumor metastasis through dual effects on cancer and endothelial cells. Oncoimmunology. 11, 2052418 (2022). https:\/\/doi.org\/10.1080\/2162402X.2022.2052418","journal-title":"Oncoimmunology"},{"key":"1013_CR26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1083\/jcb.201006052","volume":"191","author":"V Papayannopoulos","year":"2010","unstructured":"V. Papayannopoulos, K.D. Metzler, A. Hakkim, A. Zychlinsky, Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell. Biol. 191, 677\u2013691 (2010). https:\/\/doi.org\/10.1083\/jcb.201006052","journal-title":"J. Cell. Biol."},{"key":"1013_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1152\/physrev.00062.2021","volume":"103","author":"M Herre","year":"2023","unstructured":"M. Herre, J. Cedervall, N. Mackman, A.K. Olsson, Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases. Physiol. Rev. 103, 277\u2013312 (2023). https:\/\/doi.org\/10.1152\/physrev.00062.2021","journal-title":"Physiol. Rev."},{"key":"1013_CR28","doi-asserted-by":"publisher","first-page":"1253964","DOI":"10.3389\/fimmu.2023.1253964","volume":"14","author":"W Zhu","year":"2023","unstructured":"W. Zhu, C. Fan, S. Dong, X. Li, H. Chen, W. Zhou, Neutrophil extracellular traps regulating tumorimmunity in hepatocellular carcinoma. Front. Immunol. 14, 1253964 (2023). https:\/\/doi.org\/10.3389\/fimmu.2023.1253964","journal-title":"Front. Immunol."},{"key":"1013_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/cac2.12388","volume":"43","author":"X Zhan","year":"2023","unstructured":"X. Zhan, R. Wu, X.H. Kong, Y. You, K. He, X.Y. Sun, Y. Huang, W.X. Chen, L. Duan, Elevated neutrophil extracellular traps by HBV-mediated S100A9-TLR4\/RAGE-ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma. Cancer Commun. (Lond). 43, 225\u2013245 (2023). https:\/\/doi.org\/10.1002\/cac2.12388","journal-title":"Cancer Commun. (Lond)"},{"key":"1013_CR30","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/hep.29914","volume":"68","author":"DJ van der Windt","year":"2018","unstructured":"D.J. van der Windt, V. Sud, H. Zhang, P.R. Varley, J. Goswami, H.O. Yazdani, S. Tohme, P. Loughran, R.M. O\u2019Doherty, M.I. Minervini, H. Huang, R.L. Simmons, A. Tsung, Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology. 68, 1347\u20131360 (2018). https:\/\/doi.org\/10.1002\/hep.29914","journal-title":"Hepatology"},{"key":"1013_CR31","doi-asserted-by":"publisher","first-page":"18025","DOI":"10.1038\/s41598-021-97233-3","volume":"11","author":"R Zenlander","year":"2021","unstructured":"R. Zenlander, S. Havervall, M. Magnusson, J. Engstrand, A. Agren, C. Thalin, P. Stal, Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma. Sci. Rep. 11, 18025 (2021). https:\/\/doi.org\/10.1038\/s41598-021-97233-3","journal-title":"Sci. Rep."},{"key":"1013_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.21037\/hbsn-21-557","volume":"11","author":"RI Velliou","year":"2022","unstructured":"R.I. Velliou, I. Mitroulis, A. Chatzigeorgiou, Neutrophil extracellular traps contribute to the development of hepatocellular carcinoma in NASH by promoting Treg differentiation. Hepatobiliary Surg. Nutr. 11, 415\u2013418 (2022). https:\/\/doi.org\/10.21037\/hbsn-21-557","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"1013_CR33","doi-asserted-by":"publisher","unstructured":"M. Swamydas, M.S. Lionakis, Isolation, purification and labeling of mouse bone marrow neutrophils for functional studies and adoptive transfer experiments. J. Vis. Exp. e50586 (2013). https:\/\/doi.org\/10.3791\/50586","DOI":"10.3791\/50586"},{"key":"1013_CR34","doi-asserted-by":"publisher","unstructured":"J. Gao, J. Liu, J. Lu, X. Zhang, W. Zhang, Q. Li, J. Cai, M. Li, Y. Gan, Y. Tang, S. Wu, SKAP1 expression in cancer cells enhances colon tumor growth and impairs cytotoxic immunity by promoting Neutrophil Extracellular trap formation via the NFATc1\/CXCL8 Axis. Adv. Sci. (Weinh). e2403430 (2024). https:\/\/doi.org\/10.1002\/advs.202403430","DOI":"10.1002\/advs.202403430"},{"key":"1013_CR35","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1038\/s41467-021-23881-8","volume":"12","author":"Q Ou","year":"2021","unstructured":"Q. Ou, J.Q. Fang, Z.S. Zhang, Z. Chi, J. Fang, D.Y. Xu, K.Z. Lu, M.Q. Qian, D.Y. Zhang, J.P. Guo, W. Gao, N.R. Zhang, J.P. Pan, TcpC inhibits neutrophil extracellular trap formation by enhancing ubiquitination mediated degradation of peptidylarginine deiminase 4. Nat. Commun. 12, 3481 (2021). https:\/\/doi.org\/10.1038\/s41467-021-23881-8","journal-title":"Nat. Commun."},{"key":"1013_CR36","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1038\/s41467-018-06951-2","volume":"9","author":"S Corre","year":"2018","unstructured":"S. Corre, N. Tardif, N. Mouchet, H.M. Leclair, L. Boussemart, A. Gautron, L. Bachelot, A. Perrot, A. Soshilov, A. Rogiers, F. Rambow, E. Dumontet, K. Tarte, A. Bessede, G.J. Guillemin, J.C. Marine, M.S. Denison, D. Gilot, M.D. Galibert, Sustained activation of the Aryl hydrocarbon receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma. Nat. Commun. 9, 4775 (2018). https:\/\/doi.org\/10.1038\/s41467-018-06951-2","journal-title":"Nat. Commun."},{"key":"1013_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nchembio.496","volume":"7","author":"A Hakkim","year":"2011","unstructured":"A. Hakkim, T.A. Fuchs, N.E. Martinez, S. Hess, H. Prinz, A. Zychlinsky, H. Waldmann, Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nat. Chem. Biol. 7, 75\u201377 (2011). https:\/\/doi.org\/10.1038\/nchembio.496","journal-title":"Nat. Chem. Biol."},{"key":"1013_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-024-01933-x","volume":"9","author":"H Wang","year":"2024","unstructured":"H. Wang, S.J. Kim, Y. Lei, S. Wang, H. Wang, H. Huang, H. Zhang, A. Tsung, Neutrophil extracellular traps in homeostasis and disease. Signal. Transduct. Target. Ther. 9, 235 (2024). https:\/\/doi.org\/10.1038\/s41392-024-01933-x","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1013_CR39","doi-asserted-by":"publisher","first-page":"110744","DOI":"10.1016\/j.cbi.2023.110744","volume":"385","author":"D Luo","year":"2023","unstructured":"D. Luo, Y. Lu, J. Zhang, X. Wang, Y. Wang, S. Li, S. Li, The mechanism of acrolein exposure inhibited the release of neutrophil extracellular traps: by reducing respiratory burst and Raf\/MEK\/ERK pathway and promote cell apoptosis. Chem. Biol. Interact. 385, 110744 (2023). https:\/\/doi.org\/10.1016\/j.cbi.2023.110744","journal-title":"Chem. Biol. Interact."},{"key":"1013_CR40","doi-asserted-by":"publisher","first-page":"1042686","DOI":"10.3389\/fimmu.2023.1042686","volume":"14","author":"V de Carvalho Oliveira","year":"2023","unstructured":"V. de Carvalho Oliveira, O. Tatsiy, P.P. McDonald, Phosphoinositol 3-kinase-driven NET formation involves different isoforms and signaling partners depending on the stimulus. Front. Immunol. 14, 1042686 (2023). https:\/\/doi.org\/10.3389\/fimmu.2023.1042686","journal-title":"Front. Immunol."},{"key":"1013_CR41","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3389\/fimmu.2019.00746","volume":"10","author":"S Shao","year":"2019","unstructured":"S. Shao, H. Fang, E. Dang, K. Xue, J. Zhang, B. Li, H. Qiao, T. Cao, Y. Zhuang, S. Shen, T. Zhang, P. Qiao, C. Li, J.E. Gudjonsson, G. Wang, Neutrophil Extracellular traps promote inflammatory responses in Psoriasis via activating epidermal TLR4\/IL-36R crosstalk. Front. Immunol. 10, 746 (2019). https:\/\/doi.org\/10.3389\/fimmu.2019.00746","journal-title":"Front. Immunol."},{"key":"1013_CR42","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1134\/S0006297920100065","volume":"85","author":"NV Vorobjeva","year":"2020","unstructured":"N.V. Vorobjeva, B.V. Chernyak, NETosis: Molecular mechanisms, Role in Physiology and Pathology. Biochem. (Mosc). 85, 1178\u20131190 (2020). https:\/\/doi.org\/10.1134\/S0006297920100065","journal-title":"Biochem. (Mosc)"},{"key":"1013_CR43","doi-asserted-by":"publisher","first-page":"8616","DOI":"10.1074\/jbc.M116.768309","volume":"292","author":"LD Healy","year":"2017","unstructured":"L.D. Healy, C. Puy, J.A. Fernandez, A. Mitrugno, R.S. Keshari, N.A. Taku, T.T. Chu, X. Xu, A. Gruber, F. Lupu, J.H. Griffin, O.J.T. McCarty, Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo. J. Biol. Chem. 292, 8616\u20138629 (2017). https:\/\/doi.org\/10.1074\/jbc.M116.768309","journal-title":"J. Biol. Chem."},{"key":"1013_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.semcancer.2021.07.011","volume":"79","author":"L Cristinziano","year":"2022","unstructured":"L. Cristinziano, L. Modestino, A. Antonelli, G. Marone, H.U. Simon, G. Varricchi, M.R. Galdiero, Neutrophil extracellular traps in cancer. Semin Cancer Biol. 79, 91\u2013104 (2022). https:\/\/doi.org\/10.1016\/j.semcancer.2021.07.011","journal-title":"Semin Cancer Biol."},{"key":"1013_CR45","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ccell.2023.02.001","volume":"41","author":"JM Adrover","year":"2023","unstructured":"J.M. Adrover, S.A.C. McDowell, X.Y. He, D.F. Quail, M. Egeblad, NETworking with cancer: the bidirectional interplay between cancer and neutrophil extracellular traps. Cancer Cell. 41, 505\u2013526 (2023). https:\/\/doi.org\/10.1016\/j.ccell.2023.02.001","journal-title":"Cancer Cell."},{"key":"1013_CR46","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1111\/jth.15003","volume":"18","author":"C Thalin","year":"2020","unstructured":"C. Thalin, K. Aguilera, N.W. Hall, M.R. Marunde, J.M. Burg, A. Rosell, M. Daleskog, M. Mansson, Y. Hisada, M.J. Meiners, Z.W. Sun, M.F. Whelihan, M.A. Cheek, S.A. Howard, S. Saxena-Beem, D.F. Noubouossie, N.S. Key, S.Z. Sheikh, M.C. Keogh, M.W. Cowles, S. Lundstrom, N. Mackman, H. Wallen, A.L. Johnstone, Quantification of citrullinated histones: development of an improved assay to reliably quantify nucleosomal H3Cit in human plasma. J. Thromb. Haemost. 18, 2732\u20132743 (2020). https:\/\/doi.org\/10.1111\/jth.15003","journal-title":"J. Thromb. Haemost"},{"key":"1013_CR47","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1084\/jem.20100239","volume":"207","author":"P Li","year":"2010","unstructured":"P. Li, M. Li, M.R. Lindberg, M.J. Kennett, N. Xiong, Y. Wang, PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853\u20131862 (2010). https:\/\/doi.org\/10.1084\/jem.20100239","journal-title":"J. Exp. Med."},{"key":"1013_CR48","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.mucimm.2023.07.002","volume":"16","author":"B Curren","year":"2023","unstructured":"B. Curren, T. Ahmed, D.R. Howard, M. Ashik Ullah, I. Sebina, R.B. Rashid, M. Al Amin Sikder, P. Namubiru, A. Bissell, S. Ngo, D.J. Jackson, M. Toussaint, M.R. Edwards, S.L. Johnston, H.J. McSorley, S. Phipps, IL-33-induced neutrophilic inflammation and NETosis underlie rhinovirus-triggered exacerbations of asthma. Mucosal Immunol. 16, 671\u2013684 (2023). https:\/\/doi.org\/10.1016\/j.mucimm.2023.07.002","journal-title":"Mucosal Immunol."},{"key":"1013_CR49","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.4049\/jimmunol.1800627","volume":"201","author":"Z Jin","year":"2018","unstructured":"Z. Jin, L. Lei, D. Lin, Y. Liu, Y. Song, H. Gong, Y. Zhu, Y. Mei, B. Hu, Y. Wu, G. Zhang, H. Liu, IL-33 released in the liver inhibits Tumor Growth via Promotion of CD4(+) and CD8(+) T cell responses in Hepatocellular Carcinoma. J. Immunol. 201, 3770\u20133779 (2018). https:\/\/doi.org\/10.4049\/jimmunol.1800627","journal-title":"J. Immunol."},{"key":"1013_CR50","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12967-020-02661-w","volume":"18","author":"W Wang","year":"2020","unstructured":"W. Wang, J. Wu, M. Ji, C. Wu, Exogenous interleukin-33 promotes hepatocellular carcinoma growth by remodelling the tumour microenvironment. J. Transl Med. 18, 477 (2020). https:\/\/doi.org\/10.1186\/s12967-020-02661-w","journal-title":"J. Transl Med."},{"key":"1013_CR51","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12885-023-11179-5","volume":"23","author":"X Pan","year":"2023","unstructured":"X. Pan, J. Liu, M. Li, Y. Liang, Z. Liu, M. Lao, M. Fang, The association of serum IL-33\/ST2 expression with hepatocellular carcinoma. BMC Cancer. 23, 704 (2023). https:\/\/doi.org\/10.1186\/s12885-023-11179-5","journal-title":"BMC Cancer"},{"key":"1013_CR52","doi-asserted-by":"publisher","first-page":"eabq3362","DOI":"10.1126\/scisignal.abq3362","volume":"16","author":"Z Wang","year":"2023","unstructured":"Z. Wang, B. Pan, J. Qiu, X. Zhang, X. Ke, S. Shen, X. Wu, Y. Yao, N. Tang, SUMOylated IL-33 in the nucleus stabilizes the transcription factor IRF1 in hepatocellular carcinoma cells to promote immune escape. Sci. Signal. 16, eabq3362 (2023). https:\/\/doi.org\/10.1126\/scisignal.abq3362","journal-title":"Sci. Signal."},{"key":"1013_CR53","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3892\/ol.2016.4622","volume":"12","author":"Y Yang","year":"2016","unstructured":"Y. Yang, J.B. Wang, Y.M. Li, Y.U. Zhao, R. Wang, Q. Wu, R.S. Zheng, Y.R. Ou, Role of IL-33 expression in oncogenesis and development of human hepatocellular carcinoma. Oncol. Lett. 12, 429\u2013436 (2016). https:\/\/doi.org\/10.3892\/ol.2016.4622","journal-title":"Oncol. Lett."},{"key":"1013_CR54","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1158\/1078-0432.CCR-15-1987","volume":"22","author":"RK Lai","year":"2016","unstructured":"R.K. Lai, I.M. Xu, D.K. Chiu, A.P. Tse, L.L. Wei, C.T. Law, D. Lee, C.M. Wong, M.P. Wong, I.O. Ng, C.C. Wong, NDUFA4L2 fine-tunes oxidative stress in Hepatocellular Carcinoma. Clin. Cancer Res. 22, 3105\u20133117 (2016). https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1987","journal-title":"Clin. Cancer Res."},{"key":"1013_CR55","doi-asserted-by":"publisher","unstructured":"M.K. Tembhre, M.K. Sriwastva, M.P. Hote, S. Srivastava, P. Solanki, S. Imran, R. Lakshmy, A. Sharma, K. Jaiswal, A.D. Upadhyay, Interleukin-33 induces Neutrophil Extracellular trap (NET) formation and macrophage necroptosis via enhancing oxidative stress and secretion of proatherogenic factors in Advanced Atherosclerosis. Antioxidants (Basel). 11 (2022). https:\/\/doi.org\/10.3390\/antiox11122343","DOI":"10.3390\/antiox11122343"},{"key":"1013_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41420-020-0267-2","volume":"6","author":"R Jin","year":"2020","unstructured":"R. Jin, J. Xu, Q. Gao, X. Mao, J. Yin, K. Lu, Y. Guo, M. Zhang, R. Cheng, IL-33-induced neutrophil extracellular traps degrade fibronectin in a murine model of bronchopulmonary dysplasia. Cell. Death Discov. 6, 33 (2020). https:\/\/doi.org\/10.1038\/s41420-020-0267-2","journal-title":"Cell. Death Discov"},{"key":"1013_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.09.010","author":"HO Yazdani","year":"2017","unstructured":"H.O. Yazdani, H.W. Chen, S. Tohme, S. Tai, D.J. van der Windt, P. Loughran, B.R. Rosborough, V. Sud, D. Beer-Stolz, H.R. Turnquist, A. Tsung, H. Huang, IL-33 exacerbates liver sterile inflammation by amplifying neutrophil extracellular trap formation. J. Hepatol. (2017). https:\/\/doi.org\/10.1016\/j.jhep.2017.09.010","journal-title":"J. Hepatol."},{"key":"1013_CR58","doi-asserted-by":"publisher","unstructured":"A. Teijeira, S. Garasa, M. Gato, C. Alfaro, I. Migueliz, A. Cirella, C. de Andrea, M.C. Ochoa, I. Otano, I. Etxeberria, M.P. Andueza, C.P. Nieto, L. Resano, A. Azpilikueta, M. Allegretti, M. de Pizzol, M. Ponz-Sarvise, A. Rouzaut, M.F. Sanmamed, K. Schalper, M. Carleton, M. Mellado, M.E. Rodriguez-Ruiz, P. Berraondo, J.L. Perez-Gracia, I. Melero, CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity. Immunity 52, 856\u2013871 e858 (2020). https:\/\/doi.org\/10.1016\/j.immuni.2020.03.001","DOI":"10.1016\/j.immuni.2020.03.001"},{"key":"1013_CR59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41586-020-2394-6","volume":"583","author":"L Yang","year":"2020","unstructured":"L. Yang, Q. Liu, X. Zhang, X. Liu, B. Zhou, J. Chen, D. Huang, J. Li, H. Li, F. Chen, J. Liu, Y. Xing, X. Chen, S. Su, E. Song, DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature. 583, 133\u2013138 (2020). https:\/\/doi.org\/10.1038\/s41586-020-2394-6","journal-title":"Nature"},{"key":"1013_CR60","doi-asserted-by":"publisher","unstructured":"L. Aldabbous, V. Abdul-Salam, T. McKinnon, L. Duluc, J. Pepke-Zaba, M. Southwood, A.J. Ainscough, C. Hadinnapola, M.R. Wilkins, M. Toshner, B. Wojciak-Stothard, Neutrophil Extracellular traps promote angiogenesis: evidence from vascular pathology in pulmonary hypertension. Arterioscler. Thromb. Vasc Biol. 36, 2078\u20132087 (2016). https:\/\/doi.org\/10.1161\/ATVBAHA.116.307634","DOI":"10.1161\/ATVBAHA.116.307634"},{"key":"1013_CR61","doi-asserted-by":"publisher","first-page":"867516","DOI":"10.3389\/fimmu.2022.867516","volume":"13","author":"Y Wang","year":"2022","unstructured":"Y. Wang, F. Liu, L. Chen, C. Fang, S. Li, S. Yuan, X. Qian, Y. Yin, B. Yu, B. Fu, X. Zhang, Y. Li, Neutrophil Extracellular traps (NETs) promote Non-small Cell Lung Cancer Metastasis by suppressing lncRNA MIR503HG to activate the NF-kappaB\/NLRP3 inflammasome pathway. Front. Immunol. 13, 867516 (2022). https:\/\/doi.org\/10.3389\/fimmu.2022.867516","journal-title":"Front. Immunol."},{"key":"1013_CR62","doi-asserted-by":"publisher","unstructured":"K. Martins-Cardoso, V.H. Almeida, K.M. Bagri, M.I.D. Rossi, C.S. Mermelstein, S. Konig, R.Q. Monteiro, Neutrophil Extracellular traps (NETs) promote pro-metastatic phenotype in human breast cancer cells through epithelial-mesenchymal transition. Cancers (Basel). 12 (2020). https:\/\/doi.org\/10.3390\/cancers12061542","DOI":"10.3390\/cancers12061542"},{"key":"1013_CR63","doi-asserted-by":"publisher","first-page":"102297","DOI":"10.1016\/j.arr.2024.102297","volume":"97","author":"Y Yang","year":"2024","unstructured":"Y. Yang, S. Yu, C. Lv, Y. Tian, NETosis in tumour microenvironment of liver: from primary to metastatic hepatic carcinoma. Ageing Res. Rev. 97, 102297 (2024). https:\/\/doi.org\/10.1016\/j.arr.2024.102297","journal-title":"Ageing Res. Rev."},{"key":"1013_CR64","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2147\/JHC.S303588","volume":"8","author":"X Guan","year":"2021","unstructured":"X. Guan, Y. Lu, H. Zhu, S. Yu, W. Zhao, X. Chi, C. Xie, Z. Yin, The crosstalk between Cancer cells and neutrophils enhances Hepatocellular Carcinoma Metastasis via Neutrophil Extracellular traps-Associated cathepsin G component: a potential therapeutic target. J. Hepatocell Carcinoma. 8, 451\u2013465 (2021). https:\/\/doi.org\/10.2147\/JHC.S303588","journal-title":"J. Hepatocell Carcinoma"},{"key":"1013_CR65","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.7150\/jca.64170","volume":"13","author":"LY Yang","year":"2022","unstructured":"L.Y. Yang, X.T. Shen, H.T. Sun, W.W. Zhu, J.B. Zhang, L. Lu, Neutrophil extracellular traps in hepatocellular carcinoma are enriched in oxidized mitochondrial DNA which is highly pro-inflammatory and pro-metastatic. J. Cancer. 13, 1261\u20131271 (2022). https:\/\/doi.org\/10.7150\/jca.64170","journal-title":"J. Cancer"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-024-01013-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-024-01013-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-024-01013-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T08:28:15Z","timestamp":1744619295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-024-01013-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1013"],"URL":"https:\/\/doi.org\/10.1007\/s13402-024-01013-w","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"assertion":[{"value":"9 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This animal study was approved by the Animal Care and Use Committee of the First Affiliated Hospital of Zhengzhou University with procedure number 2023-KY-1343.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}